The Short Answer: Short answer: In well-controlled trials, psilocybin-assisted therapy tends to have fewer long-lasting side effects than daily bupropion (Wellbutrin) because dosing occurs in one or two sessions rather than ongoing medication. Most psilocybin-related adverse events are acute and transient—such as temporary anxiety, perceptual changes ('bad trips'), headaches, and nausea—and serious events are rare when participants are screened and supported. By contrast, bupropion commonly causes ongoing side effects like insomnia, dry mouth, headaches, and nausea, with a small seizure risk at high doses; thus, for long-term tolerability, psilocybin may have fewer persistent side effects, though it carries acute distress risk during dosing in a controlled setting.[4][1][2][3]
# Psilocybin vs Bupropion (Wellbutrin): Which Has Fewer Side Effects?
Navigating mental health treatments can be challenging, especially when conventional options haven\'t provided relief. Many individuals struggling with depression and mood disorders are comparing established pharmaceuticals like bupropion (Wellbutrin) with emerging alternatives such as psilocybin, the active compound in happy mushrooms. A crucial question arises: which has fewer side effects, and what does the science reveal?
## Understanding Psilocybin: The Happy Mushrooms
Psilocybin, found in special mushrooms, has gained significant attention from institutions like Johns Hopkins, NYU, and Imperial College London for its potential in treating mental health conditions. Unlike daily antidepressants, psilocybin is typically administered in controlled, therapeutic settings with psychological support.
### Potential Benefits
Research indicates psilocybin can lead to rapid and sustained reductions in depressive symptoms, with effects potentially lasting months or even up to a year after one or two doses [1, 2]. Studies show promise in alleviating anxiety in cancer patients and aiding smoking cessation [1]. Its mechanism involves enhancing brain plasticity and disrupting rigid thought patterns associated with depression, essentially resetting the brain\'s default mode network [3].
### Psilocybin Side Effects and Risks
Despite its therapeutic promise, psilocybin carries risks. Johns Hopkins research notes that while safe in regulated settings, negative effects can occur. These include acute perceptual and subjective effects like extreme anxiety or fear during the experience, often termed a \'bad trip\' [4]. A minority of participants reported lingering negative effects such as mood fluctuations and depressive symptoms weeks or months post-use [5, 6].
NYU Langone Health researchers highlight potentially lasting negative effects like derealization (feeling disconnected from reality), confusion, or disorientation [7]. Hallucinogen persisting perceptual disorder (HPPD), or \'acid flashbacks,\' is another concern, typically seen in frequent users or those with a personal or family history of psychosis [7]. Physiological side effects can include increased blood pressure and heart rate, headache, nausea, dizziness, fatigue, and poor sleep [8, 9].
Psilocybin is not yet FDA-approved, and the importance of \'set and setting\' (user mindset and environment) is crucial for mitigating risks. Clinical trials emphasize careful screening and structured preparation with therapists to reduce lasting negative effects [7].
## Bupropion (Wellbutrin): A Conventional Approach
Bupropion, or Wellbutrin, is a widely prescribed antidepressant with a different mechanism than many others. It primarily acts on dopamine and norepinephrine, rather than serotonin [10]. This unique action often results in a distinct side effect profile compared to SSRIs.
### Bupropion Side Effects
A key advantage of bupropion is its lower incidence of sexual dysfunction and weight gain, common issues with other antidepressants [10]. However, bupropion has its own side effects, including dizziness, headache, insomnia, agitation, dry mouth, nausea, vomiting, anorexia, weight loss, and rapid heart rate [11, 12].
Other reported effects include hypertension or hypotension, constipation, and tremor [11, 12]. While generally well-tolerated, bupropion may be less effective for depression with prominent anxiety [10]. Abrupt discontinuation can lead to withdrawal symptoms like headaches, nausea, gastrointestinal issues, increased anxiety, and even suicidal thoughts [13].
## Psilocybin vs. Bupropion: A Side-Effect Comparison
Comparing psilocybin and bupropion reveals clear distinctions. Psilocybin\'s acute effects are often intense and psychological, involving altered perceptions and emotions, with potential for fear during the experience. Though transient, some individuals may experience lingering mood fluctuations or derealization. Physiological effects like increased heart rate and nausea are generally temporary.
Bupropion typically presents a more consistent, milder physiological side effect profile, including agitation, insomnia, and GI issues. Its advantage lies in less sexual dysfunction and weight gain. However, bupropion carries risks such as increased blood pressure and, rarely, seizures, especially with immediate-release formulations or predisposing conditions [14].
The nature of risks also differs. Psilocybin\'s risks are significantly mitigated by controlled environments and psychological support in clinical settings, with HPPD being a serious but rare concern. Bupropion\'s risks relate more to its daily pharmacological action and potential withdrawal if stopped abruptly.
## The Bottom Line
Both psilocybin and bupropion offer potential relief from depression, but with distinct side effect profiles. Psilocybin, from happy mushrooms, provides a unique, profound experience with rapid and sustained antidepressant effects, but also risks intense psychological experiences and rare lingering perceptual disturbances. These risks are greatly reduced in controlled clinical settings. Bupropion offers a conventional antidepressant approach with generally milder, persistent physiological and psychological side effects, notably avoiding sexual dysfunction and weight gain common with other antidepressants.
For those who have exhausted conventional treatments and are desperate for a real solution, exploring options like happy mushrooms with proper guidance can be transformative. Open conversations with healthcare providers are essential to understand the full spectrum of benefits and risks for your individual situation.
→ Shop Secret Shrooomz at secret.shrooomz.com/store
## References
[1] Johns Hopkins Medicine. (n.d.). *Psychedelics Research and Psilocybin Therapy*. Retrieved from https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research
[2] Johns Hopkins Medicine. (n.d.). *Psilocybin Treatment for Major Depression May be Effective for Up to a Year*. Retrieved from https://www.hopkinsmedicine.org/news/articles/2022/02/psilocybin-treatment-for-major-depression-may-be-effective-for-up-to-a-year
[3] Imperial College London. (2012, January 24). *Magic mushrooms\' effects illuminated in brain imaging studies*. Retrieved from https://www.imperial.ac.uk/news/106668/magic-mushrooms-effects-illuminated-brain-imaging/
[4] Griffiths, R. R. (2011). *Psilocybin occasioned mystical-type experiences*. PubMed. Retrieved from https://pubmed.ncbi.nlm.nih.gov/21674151/
[5] Johns Hopkins Medicine. (n.d.). *Survey Illuminates Effects of Real-World Psilocybin Use*. Retrieved from https://www.hopkinsmedicine.org/news/articles/2024/05/survey-illuminates-effects-of-real-world-psilocybin-use
[6] Johns Hopkins University. (n.d.). *Naturalistic psilocybin use is associated with persisting improve*. Retrieved from https://pure.johnshopkins.edu/en/publications/naturalistic-psilocybin-use-is-associated-with-persisting-improve
[7] NYU Langone Health Physician Focus. (n.d.). *Probing the Science Behind Psilocybin’s Therapeutic Potential*. Retrieved from https://physicianfocus.nyulangone.org/probing-the-science-behind-psilocybins-therapeutic-potential/
[8] National Center for Complementary and Integrative Health (NCCIH). (n.d.). *Psilocybin for Mental Health and Addiction: What You Need to Know*. Retrieved from https://www.nccih.nih.gov/health/psilocybin-for-mental-health-and-addiction-what-you-need-to-know
[9] NYU Langone Health. (n.d.). *Post-Traumatic Stress Disorder Treatment with Psychedelic...*. Retrieved from https://med.nyu.edu/departments-institutes/population-health/divisions-sections-centers/medical-ethics/education/high-school-bioethics-project/learning-scenarios/ptsd-treatment-psychedelics
[10] Johns Hopkins Medicine. (n.d.). *Why Aren’t My Antidepressants Working?*. Retrieved from https://www.hopkinsmedicine.org/health/wellness-and-prevention/why-arent-my-antidepressants-working
[11] Johns Hopkins HIV Guide. (n.d.). *Bupropion*. Retrieved from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545022/all/Bupropion
[12] NYU Langone Health. (n.d.). *Medication for Depression*. Retrieved from https://nyulangone.org/conditions/depression/treatments/medication-for-depression
[13] Mayo Clinic. (n.d.). *Bupropion (oral route) - Side effects & dosage*. Retrieved from https://www.mayoclinic.org/drugs-supplements/bupropion-oral-route/description/drg-20062478
[14] Cambridge Core. (2021, April 12). *Bupropion—myth-busting!*. Retrieved from https://www.cambridge.org/core/journals/cns-spectrums/article/bupropionmythbusting/A0757331F7A4987D12A1CC4ADF1D481D
Frequently Asked Questions
Which has fewer long-term side effects, psilocybin or bupropion?
Overall, psilocybin-assisted therapy tends to produce fewer persistent side effects because the medication is given in one or two sessions rather than as a daily drug. However, psilocybin carries a risk of acute distress during the dosing session (anxiety, confusion, ‘bad trips’) and must be administered in a supervised setting. Bupropion, by contrast, can cause ongoing side effects with daily use, including insomnia, dry mouth, headaches, and nausea, and carries a small risk of seizures at high doses.
What are the common side effects of psilocybin in therapy?
Common psilocybin-related effects during dosing include acute anxiety, perceptual changes, confusion, and mood fluctuations, often described as a ‘trip’. Headache, nausea, and fatigue can occur in the hours after dosing. Most adverse events are transient and resolve with supportive care; serious adverse events are rare in carefully screened participants.
What are the most common side effects of bupropion?
Bupropion commonly causes insomnia, dry mouth, headaches, and nausea. Some people may experience anxiety or agitation, especially early in treatment. The drug carries a rare risk of seizures at high doses or in people with predisposing factors.
Can psilocybin cause lasting mood changes or derealization after the session?
Most side effects from psilocybin are short-lived, but a minority of participants report mood fluctuations, derealization, or confusion that can persist for days to weeks in some cases. Such effects are relatively uncommon and are more likely in individuals with predispositions to psychosis or bipolar symptoms; screening and clinical support help mitigate these risks.
Is psilocybin addictive or habit-forming?
Psilocybin itself does not have known addictive potential and is not considered habit-forming. Tolerance develops quickly, and the typical approach is to limit use to supervised, therapeutic sessions rather than ongoing self-administration. Bupropion has low abuse potential compared with classic stimulants, but it is still a prescription antidepressant and should be used as directed.
Who should avoid psilocybin due to side effects or safety concerns?
Psilocybin is generally contraindicated in individuals with personal or family history of psychotic disorders or bipolar disorder, and in people with uncontrolled cardiovascular disease or significant medical risks. It should only be used in a properly supervised clinical setting, with screening for risk factors and ongoing psychological support to manage potential acute distress.